IPSEN (IPN.PA) Stock Fundamental Analysis
EPA:IPN - Euronext Paris - Matif - FR0010259150 - Common Stock - Currency: EUR
IPN gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 52 industry peers in the Pharmaceuticals industry. While IPN has a great health rating, its profitability is only average at the moment. IPN is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
IPN had positive earnings in the past year.
IPN had a positive operating cash flow in the past year.
IPN had positive earnings in each of the past 5 years.
In the past 5 years IPN always reported a positive cash flow from operatings.
1.2 Ratios
IPN's Return On Assets of 6.56% is in line compared to the rest of the industry. IPN outperforms 57.69% of its industry peers.
With a Return On Equity value of 10.59%, IPN perfoms like the industry average, outperforming 48.08% of the companies in the same industry.
The Return On Invested Capital of IPN (14.88%) is better than 76.92% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IPN is below the industry average of 15.11%.
The last Return On Invested Capital (14.88%) for IPN is above the 3 year average (12.97%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROIC | 14.88% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
1.3 Margins
The Profit Margin of IPN (11.91%) is comparable to the rest of the industry.
IPN's Profit Margin has declined in the last couple of years.
IPN has a Operating Margin of 26.01%. This is in the better half of the industry: IPN outperforms 71.15% of its industry peers.
In the last couple of years the Operating Margin of IPN has declined.
With an excellent Gross Margin value of 83.32%, IPN belongs to the best of the industry, outperforming 86.54% of the companies in the same industry.
In the last couple of years the Gross Margin of IPN has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% |
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), IPN is creating value.
IPN has more shares outstanding than it did 1 year ago.
IPN has about the same amout of shares outstanding than it did 5 years ago.
IPN has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 4.36 indicates that IPN is not in any danger for bankruptcy at the moment.
IPN has a better Altman-Z score (4.36) than 69.23% of its industry peers.
The Debt to FCF ratio of IPN is 1.69, which is an excellent value as it means it would take IPN, only 1.69 years of fcf income to pay off all of its debts.
IPN has a better Debt to FCF ratio (1.69) than 90.38% of its industry peers.
A Debt/Equity ratio of 0.20 indicates that IPN is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.20, IPN is doing good in the industry, outperforming 76.92% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Altman-Z | 4.36 |
ROIC/WACC1.96
WACC7.6%
2.3 Liquidity
IPN has a Current Ratio of 1.98. This is a normal value and indicates that IPN is financially healthy and should not expect problems in meeting its short term obligations.
IPN has a Current ratio of 1.98. This is in the better half of the industry: IPN outperforms 73.08% of its industry peers.
A Quick Ratio of 1.80 indicates that IPN should not have too much problems paying its short term obligations.
The Quick ratio of IPN (1.80) is better than 82.69% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 12.24% over the past year.
IPN shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 8.79% yearly.
IPN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.45%.
IPN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.83% yearly.
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
3.2 Future
IPN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.13% yearly.
Based on estimates for the next years, IPN will show a small growth in Revenue. The Revenue will grow by 4.86% on average per year.
EPS Next Y1.78%
EPS Next 2Y4.08%
EPS Next 3Y5.64%
EPS Next 5Y5.13%
Revenue Next Year6.62%
Revenue Next 2Y5.71%
Revenue Next 3Y6.08%
Revenue Next 5Y4.86%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 11.32, the valuation of IPN can be described as reasonable.
76.92% of the companies in the same industry are more expensive than IPN, based on the Price/Earnings ratio.
IPN is valuated cheaply when we compare the Price/Earnings ratio to 26.86, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 10.45, the valuation of IPN can be described as reasonable.
71.15% of the companies in the same industry are more expensive than IPN, based on the Price/Forward Earnings ratio.
IPN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.32 | ||
| Fwd PE | 10.45 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IPN indicates a rather cheap valuation: IPN is cheaper than 94.23% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IPN indicates a somewhat cheap valuation: IPN is cheaper than 63.46% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.9 | ||
| EV/EBITDA | 5.43 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IPN does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of IPN may justify a higher PE ratio.
PEG (NY)6.35
PEG (5Y)1.29
EPS Next 2Y4.08%
EPS Next 3Y5.64%
5. Dividend
5.1 Amount
IPN has a Yearly Dividend Yield of 1.26%.
Compared to an average industry Dividend Yield of 3.18, IPN has a dividend in line with its industry peers.
With a Dividend Yield of 1.26, IPN pays less dividend than the S&P500 average, which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.26% |
5.2 History
The dividend of IPN has a limited annual growth rate of 3.72%.
Dividend Growth(5Y)3.72%
Div Incr Years1
Div Non Decr Years4
5.3 Sustainability
IPN pays out 25.90% of its income as dividend. This is a sustainable payout ratio.
The dividend of IPN is growing, but earnings are growing more, so the dividend growth is sustainable.
DP25.9%
EPS Next 2Y4.08%
EPS Next 3Y5.64%
EPA:IPN (8/21/2025, 5:36:15 PM)
116.3
+0.7 (+0.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners14.53%
Inst Owner ChangeN/A
Ins Owners0.27%
Ins Owner ChangeN/A
Market Cap9.75B
Analysts68.42
Price Target129.03 (10.95%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.26% |
Yearly Dividend1.2
Dividend Growth(5Y)3.72%
DP25.9%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.27%
PT rev (3m)1.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-0.11%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.32 | ||
| Fwd PE | 10.45 | ||
| P/S | 2.59 | ||
| P/FCF | 18.9 | ||
| P/OCF | 10.86 | ||
| P/B | 2.3 | ||
| P/tB | 7.3 | ||
| EV/EBITDA | 5.43 |
EPS(TTM)10.27
EY8.83%
EPS(NY)11.13
Fwd EY9.57%
FCF(TTM)6.15
FCFY5.29%
OCF(TTM)10.71
OCFY9.2%
SpS44.86
BVpS50.46
TBVpS15.93
PEG (NY)6.35
PEG (5Y)1.29
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROCE | 18.07% | ||
| ROIC | 14.88% | ||
| ROICexc | 20.46% | ||
| ROICexgc | 77.25% | ||
| OM | 26.01% | ||
| PM (TTM) | 11.91% | ||
| GM | 83.32% | ||
| FCFM | 13.72% |
ROA(3y)9.04%
ROA(5y)10.56%
ROE(3y)14.84%
ROE(5y)18.77%
ROIC(3y)12.97%
ROIC(5y)15.34%
ROICexc(3y)20.33%
ROICexc(5y)25.52%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)15.75%
ROCE(5y)18.64%
ROICexcg growth 3Y-59.92%
ROICexcg growth 5Y-22.83%
ROICexc growth 3Y-29.05%
ROICexc growth 5Y-11.89%
OM growth 3Y-13.94%
OM growth 5Y-4.28%
PM growth 3Y-25.63%
PM growth 5YN/A
GM growth 3Y-0.54%
GM growth 5Y0.2%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.69 | ||
| Debt/EBITDA | 0.5 | ||
| Cap/Depr | 55.54% | ||
| Cap/Sales | 10.15% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 53.9% | ||
| Profit Quality | 115.14% | ||
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 | ||
| Altman-Z | 4.36 |
F-Score7
WACC7.6%
ROIC/WACC1.96
Cap/Depr(3y)131.36%
Cap/Depr(5y)124.73%
Cap/Sales(3y)11.81%
Cap/Sales(5y)11.18%
Profit Quality(3y)85.87%
Profit Quality(5y)89.99%
High Growth Momentum
Growth
EPS 1Y (TTM)12.24%
EPS 3Y4.15%
EPS 5Y8.79%
EPS Q2Q%44.4%
EPS Next Y1.78%
EPS Next 2Y4.08%
EPS Next 3Y5.64%
EPS Next 5Y5.13%
Revenue 1Y (TTM)9.45%
Revenue growth 3Y9.15%
Revenue growth 5Y5.83%
Sales Q2Q%9.67%
Revenue Next Year6.62%
Revenue Next 2Y5.71%
Revenue Next 3Y6.08%
Revenue Next 5Y4.86%
EBIT growth 1Y66.72%
EBIT growth 3Y-6.06%
EBIT growth 5Y1.3%
EBIT Next Year27.18%
EBIT Next 3Y13.1%
EBIT Next 5Y7.49%
FCF growth 1Y-33.64%
FCF growth 3Y-35.67%
FCF growth 5Y-17.46%
OCF growth 1Y-8.92%
OCF growth 3Y-0.07%
OCF growth 5Y7.84%